The role of thrombolytics in acute and chronic occlusion of the hand.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25455353.
- Also identified by DOI 10.1016/j.hcl.2014.09.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Distal arm and hand ischemia from vessel thrombosis or embolism remains a difficult clinical challenge. The causes of ischemia are variable and include connective tissue disease, embolism, atherosclerosis, and iatrogenic etiology. Although reports are limited, treatment with catheter-directed thrombolysis has favorable results in cases of acute thrombosis, with most patients (80%) demonstrating improvement. Digital amputation rates are less than 10% and the hand is often salvaged. Bleeding and access-site complications remain prevalent in patients undergoing intra-arterial thrombolysis. This review discusses etiology, treatment approaches, outcomes, and complications when thrombolytic therapy is used for distal arm and hand ischemia.
Medical subject headings
- Fibrinolytic Agents
- Hand
- Ischemia
- Thrombosis
Anatomy
- hand